| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Tyson John R. | Senior Vice President | 2200 W. DON TYSON PARKWAY, SPRINGDALE | /s/ Marissa Savells by Power of Attorney for John R. Tyson | 2025-11-19 | 0001788444 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | TSN | Class A Common Stock | Tax liability | -$75.6K | -1.42K | -3.52% | $53.11 | 39.1K | Nov 17, 2025 | Direct | F1 |
| transaction | TSN | Class A Common Stock | Options Exercise | +3.85K | +9.85% | 42.9K | Nov 17, 2025 | Direct | F2 | ||
| transaction | TSN | Class A Common Stock | Tax liability | -$58.7K | -1.11K | -2.58% | $53.11 | 41.8K | Nov 17, 2025 | Direct | F3 |
| transaction | TSN | Class A Common Stock | Tax liability | -$128K | -2.39K | -5.61% | $53.66 | 40.2K | Nov 18, 2025 | Direct | F4, F5, F6 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | TSN | Performance Shares | Options Exercise | -30.5K | -100% | 0 | Nov 18, 2025 | Class A Common Stock | 30.5K | Direct | F7 | |||
| transaction | TSN | Performance Shares | Options Exercise | -3.85K | -100% | 0 | Nov 17, 2025 | Class A Common Stock | 3.85K | Direct | F8 |
| Id | Content |
|---|---|
| F1 | On November 17, 2025, 5,040.36 restricted Class A Common Stock vested. The restricted shares were previously reported as beneficially owned by the Reporting Person. Pursuant to the terms of the award agreement these shares were withheld by the Issuer to satisfy tax withholding obligations. |
| F2 | On November 17, 2025, 3,846.944 shares vested and are reported herein as acquired non-derivative securities. On November 17, 2023, the Reporting Person received a grant of performance shares which would vest in equal installments over two years, and one-half of which vested on November 17, 2024, subject to the achievement of a performance metric in the applicable Stock Incentive Agreement. The performance metric was a cumulative operating income target of $1.161 billion for the 2024 fiscal year. The performance shares could vest at a level of 25 percent - 100 percent per performance criteria and were previously reported in the aggregate as derivative securities at the 100 percent level. |
| F3 | Pursuant to the terms of the award agreement, these shares were withheld by the Issuer to satisfy tax withholding obligations related to the vesting described in footnote 2. |
| F4 | On November 18, 2025, 8,389.873 shares of restricted Class A Common Stock vested. The restricted shares were previously reported as beneficially owned by the Reporting Person. Pursuant to the terms of the award agreement these shares were withheld by the Issuer to satisfy tax withholding obligations. |
| F5 | Includes 256.455 shares of the Issuer's Class A Common Stock purchased for the Reporting Person's account under the Issuer's Employee Stock Purchase Plan since the last Statement of Changes in Beneficial Ownership was filed by the Reporting Person. Such acquisitions are exempt from Section 16 concurrent reporting requirements pursuant to Rule 16b-3. |
| F6 | Includes 568.072 shares of the Issuer's Class A Common Stock received by the Reporting Person pursuant to the Issuer's dividend reinvestment plan since the last Statement of Changes in Beneficial Ownership was filed by the Reporting Person. Such acquisitions are exempt from Section 16 concurrent reporting requirements pursuant to Rule 16a-11. |
| F7 | On November 18, 2025, the Reporting Person's grant of performance shares expired without any shares vesting. On November 18, 2022, the Reporting Person received a grant of performance shares, subject to the achievement of performance criteria in the applicable Stock Incentive Agreement. The performance criteria were (a) a cumulative operating income target of $12 billion for the 2023-2025 fiscal years and (b) a favorable comparison of the relative shareholder return of the Issuer's Class A Common Stock compared to a predetermined peer group of publicly traded companies over the 2022-2024 fiscal years, and (c) a cumulative return on invested capital of 11.5% for the 2023-2025 fiscal years. The performance shares could have vested at a level of up to 200 percent per performance criteria and were previously reported in the aggregate as derivative securities at the 200 percent level. |
| F8 | These performance shares vested as described in footnote 2. |